Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ALS (Amyotrophic Lateral Sclerosis)”

981 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 981 results

Testing effectiveness (Phase 2)Study completedNCT00036413
What this trial is testing

A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Novartis Pharmaceuticals 44
Not applicableStudy completedNCT03613038
What this trial is testing

A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria

Who this might be right for
Amyotrophic Lateral SclerosisParkinson Disease
University of Missouri-Columbia 100
Testing effectiveness (Phase 2)Study completedNCT00005674
What this trial is testing

Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]

Who this might be right for
Amyotrophic Lateral Sclerosis
National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Ended earlyNCT05053035
What this trial is testing

Evaluate AL001 in C9orf72-Associated ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Alector Inc. 5
Not applicableAvailableNCT07088159
What this trial is testing

Intermediate-size Patient Population Expanded Access Protocol

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Spinogenix
Not applicableUnknownNCT04089696
What this trial is testing

Validation of the "ExSpiron©" in Patients With ALS

Who this might be right for
Amyotrophic Lateral SclerosisNeuromuscular Diseases
University Medical Center Groningen 10
Not applicableEnded earlyNCT00718445
What this trial is testing

Pennsylvania Consortium: Clinical Database

Who this might be right for
Amyotrophic Lateral SclerosisNeurodegenerative DiseaseMotor Neuron Disease
Drexel University College of Medicine 25
Not applicableLooking for participantsNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Early research (Phase 1)Study completedNCT01142856
What this trial is testing

Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Mayo Clinic 1
Early research (Phase 1)Study completedNCT05889572
What this trial is testing

Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisALS
MaaT Pharma 15
Not applicableStudy completedNCT01119001
What this trial is testing

A P300 Brain Computer Interface Keyboard to Control Assistive Technology For Use by People With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Michigan 13
Not applicableStudy completedNCT04950231
What this trial is testing

Investigation on Home Care Needs of ALS Patients and Their Caregivers

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00324454
What this trial is testing

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Who this might be right for
Motor Neuron DiseaseAmyotrophic Lateral SclerosisPrimary Lateral Sclerosis+1 more
Duke University 20
Early research (Phase 1)Ended earlyNCT01999803
What this trial is testing

A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Newron Sweden AB 15
Not applicableStudy completedNCT00015444
What this trial is testing

Screening and Natural History: Primary Lateral Sclerosis and Related Disorders

Who this might be right for
Primary Lateral Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 189
Testing effectiveness (Phase 2)UnknownNCT04744532
What this trial is testing

IPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Kyoto University 49
Not applicableUnknownNCT00420719
What this trial is testing

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Synapse Biomedical 100
Not applicableUnknownNCT06426030
What this trial is testing

Validation of Czech Language Versions of Questionnaires for ALS Patients' Functional Status and Biomarker Long-term Follow-up

Who this might be right for
Amyotrophic Lateral Sclerosis
Masaryk University 100
Not applicableStudy completedNCT03986671
What this trial is testing

Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx

Who this might be right for
Obstructive Sleep ApneaAmyotrophic Lateral SclerosisMuscular Dystrophies+1 more
Powell Mansfield Inc. 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06100276
What this trial is testing

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
UniQure Biopharma B.V. 20
Load More Results